Dual FGF-2 and intergrin α5β1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy

Judith Barrios, Robert Wieder

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Interactions with the bone marrow stroma regulate dormancy and survival of breast cancer micrometastases. In an in vitro model of dormancy in the bone marrow, we previously demonstrated that estrogen-dependent breast cancer cells are partially re-differentiated by FGF-2, re-express integrin α5β1 lost with malignant transformation and acquire an activated PI3K/Akt pathway. Ligation of integrin α5β1 by fibronectin and activation of the PI3K pathway both contribute to survival of these dormant cells. Here, we investigated mechanisms responsible for the dormant phenotype. Experiments demonstrate that integrin α5β1 controls de novo cytoskeletal rearrangements, cell spreading, focal adhesion kinase rearrangement to the cell perimeter and recruitment of a RhoA GAP known as GRAF. This results in the inactivation of RhoA, an effect which is necessary for the stabilization of cortical actin. Experiments also demonstrate that activation of the PI3K pathway by FGF-2 is independent of integrin α5β1 and is also required for cortical actin reorganization, GRAF membrane relocalization and RhoA inactivation. These data suggest that GRAF-mediated RhoA inactivation and consequent phenotypic changes of dormancy depend on dual signaling by FGF-2-initiated PI3K activation and through ligation of integrin α5β1 by fibronectin.

Original languageEnglish (US)
Pages (from-to)33-47
Number of pages15
JournalCancer Microenvironment
Volume2
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Fibroblast Growth Factor 2
Integrins
Phosphatidylinositol 3-Kinases
Breast Neoplasms
Fibronectins
Ligation
Actins
Bone Marrow
Focal Adhesion Protein-Tyrosine Kinases
Neoplasm Micrometastasis
Cell Survival
Estrogens
Phenotype
Membranes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Keywords

  • Breast cancer
  • Dormancy
  • Fibronectin
  • GRAF
  • Integrin α5β1
  • Micrometastases
  • PI3 kinase
  • Rho GTPases

Cite this

@article{9d3128640701435d90a3d2e2a4da8808,
title = "Dual FGF-2 and intergrin α5β1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy",
abstract = "Interactions with the bone marrow stroma regulate dormancy and survival of breast cancer micrometastases. In an in vitro model of dormancy in the bone marrow, we previously demonstrated that estrogen-dependent breast cancer cells are partially re-differentiated by FGF-2, re-express integrin α5β1 lost with malignant transformation and acquire an activated PI3K/Akt pathway. Ligation of integrin α5β1 by fibronectin and activation of the PI3K pathway both contribute to survival of these dormant cells. Here, we investigated mechanisms responsible for the dormant phenotype. Experiments demonstrate that integrin α5β1 controls de novo cytoskeletal rearrangements, cell spreading, focal adhesion kinase rearrangement to the cell perimeter and recruitment of a RhoA GAP known as GRAF. This results in the inactivation of RhoA, an effect which is necessary for the stabilization of cortical actin. Experiments also demonstrate that activation of the PI3K pathway by FGF-2 is independent of integrin α5β1 and is also required for cortical actin reorganization, GRAF membrane relocalization and RhoA inactivation. These data suggest that GRAF-mediated RhoA inactivation and consequent phenotypic changes of dormancy depend on dual signaling by FGF-2-initiated PI3K activation and through ligation of integrin α5β1 by fibronectin.",
keywords = "Breast cancer, Dormancy, Fibronectin, GRAF, Integrin α5β1, Micrometastases, PI3 kinase, Rho GTPases",
author = "Judith Barrios and Robert Wieder",
year = "2009",
month = "1",
day = "1",
doi = "10.1007/s12307-009-0019-6",
language = "English (US)",
volume = "2",
pages = "33--47",
journal = "Cancer Microenvironment",
issn = "1875-2292",
publisher = "Springer Netherlands",
number = "1",

}

Dual FGF-2 and intergrin α5β1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy. / Barrios, Judith; Wieder, Robert.

In: Cancer Microenvironment, Vol. 2, No. 1, 01.01.2009, p. 33-47.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Dual FGF-2 and intergrin α5β1 signaling mediate GRAF-induced RhoA inactivation in a model of breast cancer dormancy

AU - Barrios, Judith

AU - Wieder, Robert

PY - 2009/1/1

Y1 - 2009/1/1

N2 - Interactions with the bone marrow stroma regulate dormancy and survival of breast cancer micrometastases. In an in vitro model of dormancy in the bone marrow, we previously demonstrated that estrogen-dependent breast cancer cells are partially re-differentiated by FGF-2, re-express integrin α5β1 lost with malignant transformation and acquire an activated PI3K/Akt pathway. Ligation of integrin α5β1 by fibronectin and activation of the PI3K pathway both contribute to survival of these dormant cells. Here, we investigated mechanisms responsible for the dormant phenotype. Experiments demonstrate that integrin α5β1 controls de novo cytoskeletal rearrangements, cell spreading, focal adhesion kinase rearrangement to the cell perimeter and recruitment of a RhoA GAP known as GRAF. This results in the inactivation of RhoA, an effect which is necessary for the stabilization of cortical actin. Experiments also demonstrate that activation of the PI3K pathway by FGF-2 is independent of integrin α5β1 and is also required for cortical actin reorganization, GRAF membrane relocalization and RhoA inactivation. These data suggest that GRAF-mediated RhoA inactivation and consequent phenotypic changes of dormancy depend on dual signaling by FGF-2-initiated PI3K activation and through ligation of integrin α5β1 by fibronectin.

AB - Interactions with the bone marrow stroma regulate dormancy and survival of breast cancer micrometastases. In an in vitro model of dormancy in the bone marrow, we previously demonstrated that estrogen-dependent breast cancer cells are partially re-differentiated by FGF-2, re-express integrin α5β1 lost with malignant transformation and acquire an activated PI3K/Akt pathway. Ligation of integrin α5β1 by fibronectin and activation of the PI3K pathway both contribute to survival of these dormant cells. Here, we investigated mechanisms responsible for the dormant phenotype. Experiments demonstrate that integrin α5β1 controls de novo cytoskeletal rearrangements, cell spreading, focal adhesion kinase rearrangement to the cell perimeter and recruitment of a RhoA GAP known as GRAF. This results in the inactivation of RhoA, an effect which is necessary for the stabilization of cortical actin. Experiments also demonstrate that activation of the PI3K pathway by FGF-2 is independent of integrin α5β1 and is also required for cortical actin reorganization, GRAF membrane relocalization and RhoA inactivation. These data suggest that GRAF-mediated RhoA inactivation and consequent phenotypic changes of dormancy depend on dual signaling by FGF-2-initiated PI3K activation and through ligation of integrin α5β1 by fibronectin.

KW - Breast cancer

KW - Dormancy

KW - Fibronectin

KW - GRAF

KW - Integrin α5β1

KW - Micrometastases

KW - PI3 kinase

KW - Rho GTPases

UR - http://www.scopus.com/inward/record.url?scp=73449109119&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73449109119&partnerID=8YFLogxK

U2 - 10.1007/s12307-009-0019-6

DO - 10.1007/s12307-009-0019-6

M3 - Article

C2 - 19308677

AN - SCOPUS:73449109119

VL - 2

SP - 33

EP - 47

JO - Cancer Microenvironment

JF - Cancer Microenvironment

SN - 1875-2292

IS - 1

ER -